Clinical Trials Directory

Trials / Completed

CompletedNCT04395599

Risk of Air Contamination During Visceral Surgery in COVID19 Patients

Assessment of Air Contamination Risk by Sars-Cov2 During Visceral Surgery in COVID19 Patients: Pilot Study.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Sars-Cov2 has been found in the digestive tract, as well as the respiratory tract. Protection of health care workers during surgery has been increased and some guidelines advocate for abandoning laparoscopy in COVID19 patients for fear of contamination, evenghtough this does not benefit the patient. However, Sars-Cov2 contamination risk during visceral surgery remains unknown. Inadequate protection is unnecessary costful and can be inefficient if too binding. Our hypotheses are that 1) Sars-Cov 2 can travel through droplet and air during visceral surgery. 2) Laparoscopy, because of the pneumoperitoneum and its leaks, warrant more air contamination whereas laparotomy warrant more droplet contamination, which would justified increased protection.

Conditions

Interventions

TypeNameDescription
OTHERCartography of air contamination, environment contamination and biological fluid by Sars-Cov2 during visceral surgery in COVID19 patients.Air sampling, operating room surfaces sampling and patients' biological fluid sampling for Sars-Cov2 quantification

Timeline

Start date
2021-11-16
Primary completion
2022-01-27
Completion
2022-01-27
First posted
2020-05-20
Last updated
2025-12-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04395599. Inclusion in this directory is not an endorsement.